Francke, K.; Rottmann, A.; Klein, S.; Höchel, J.; Friedrich, C.
Investigation of the Relevance of CYP3A4 Inhibition on the Pharmacokinetics of the Novel P2X3 Antagonist Filapixant: Results of In Vitro Explorations and a Fixed-Sequence Clinical Trial with Itraconazole in Healthy Volunteers. Int. J. Mol. Sci. 2025, 26, 10177.
https://doi.org/10.3390/ijms262010177
AMA Style
Francke K, Rottmann A, Klein S, Höchel J, Friedrich C.
Investigation of the Relevance of CYP3A4 Inhibition on the Pharmacokinetics of the Novel P2X3 Antagonist Filapixant: Results of In Vitro Explorations and a Fixed-Sequence Clinical Trial with Itraconazole in Healthy Volunteers. International Journal of Molecular Sciences. 2025; 26(20):10177.
https://doi.org/10.3390/ijms262010177
Chicago/Turabian Style
Francke, Klaus, Antje Rottmann, Stefan Klein, Joachim Höchel, and Christian Friedrich.
2025. "Investigation of the Relevance of CYP3A4 Inhibition on the Pharmacokinetics of the Novel P2X3 Antagonist Filapixant: Results of In Vitro Explorations and a Fixed-Sequence Clinical Trial with Itraconazole in Healthy Volunteers" International Journal of Molecular Sciences 26, no. 20: 10177.
https://doi.org/10.3390/ijms262010177
APA Style
Francke, K., Rottmann, A., Klein, S., Höchel, J., & Friedrich, C.
(2025). Investigation of the Relevance of CYP3A4 Inhibition on the Pharmacokinetics of the Novel P2X3 Antagonist Filapixant: Results of In Vitro Explorations and a Fixed-Sequence Clinical Trial with Itraconazole in Healthy Volunteers. International Journal of Molecular Sciences, 26(20), 10177.
https://doi.org/10.3390/ijms262010177
